NEW YORK (GenomeWeb) – Natera and the Mount Sinai Genetic Testing Laboratory today announced a partnership to offer Natera's genetic carrier screening test.
The partnership allows Natera to broaden the test called Horizon to include 38 disorders, including an expanded panel designed specifically for Ashkenazi Jewish families, Natera CEO Matthew Rabinowitz said in a statement. The test also provides results for genetic disorders, such as cystic fibrosis, spinal muscular atrophy (SMA), and Tay-Sachs disease. Additionally, the expanded test increases detection rates for SMA over previous testing methods and refines risks for Fragile X syndrome, Natera said.
The Mount Sinai Genetic Testing Laboratory is part of the Icahn School of Medicine at Mount Sinai and offers screening tests for more than 100 disorders. Genetic screening is performed to determine whether an individual is a carrier for certain recessive genetic disorders.
"This is an important addition to Natera's product offering, as we are committed to expanding the breadth of genetic testing services that Natera delivers on a direct basis to our growing network of women's healthcare providers," Rabinowitz said.
Financial and other terms of the partnership were not disclosed.